Immuneering IMRX
NASDAQ IMRX
$4.07 +0.04 (+0.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuneering (IMRX) Price to Sales (2021 - 2023)

Updated

Immuneering's (IMRX) Price to Sales came in at 494037.02 for Q3 2023, compared with 747.13 a year earlier.

Analysis

Immuneering (IMRX) Price to Sales (2021 - 2023) Analysis & Trends

For FY2022, Immuneering's Price to Sales stood at 404.26, up 282.0% from FY2021.

  • In prior years, Immuneering's Price to Sales was 105.83 in FY2021.
  • The Q3 2023 figure stands as the highest quarterly Price to Sales in data going back to Q3 2021.
  • According to Business Quant data, Price to Sales for the three prior quarters was 7640.71 (Q2 2023), 1930.71 (Q1 2023) and 404.26 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Immuneering 260.73 Mn 260.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 494,037.02
Jun 30, 2023 7,640.71
Mar 31, 2023 1,930.71
Dec 31, 2022 404.26
Sep 30, 2022 747.13
Jun 30, 2022 150.32
Mar 31, 2022 112.64
Dec 31, 2021 105.83
Sep 30, 2021 189.99
API Access

Immuneering Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=IMRX&period=max&api_key=YOUR_API_KEY